Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yen, Chia-Jui"'
Autor:
Kim, Richard D, Sarker, Debashis, Meyer, Tim, Yau, Thomas, Macarulla, Teresa, Park, Joong-Won, Choo, Su Pin, Hollebecque, Antoine, Sung, Max W, Lim, Ho-Yeong, Mazzaferro, Vincenzo, Trojan, Joerg, Zhu, Andrew X, Yoon, Jung-Hwan, Sharma, Sunil, Lin, Zhong-Zhe, Chan, Stephen L, Faivre, Sandrine, Feun, Lynn G, Yen, Chia-Jui, Dufour, Jean-François, Palmer, Daniel H, Llovet, Josep M, Manoogian, Melissa, Tugnait, Meera, Stransky, Nicolas, Hagel, Margit, Kohl, Nancy E, Lengauer, Christoph, Sherwin, Cori Ann, Schmidt-Kittler, Oleg, Hoeflich, Klaus P, Shi, Hongliang, Wolf, Beni B, Kang, Yoon-Koo
Outcomes for patients with advanced hepatocellular carcinoma (HCC) remain poor despite recent progress in drug development. Emerging data implicate FGF19 as a potential HCC driver, suggesting its receptor, FGFR4, as a novel therapeutic target. We eva
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bfc1d7bd576921a69ccdc26707b0b15
Autor:
Lim, Ho Yeong, Merle, Philippe, Weiss, Karl Heinz, Yau, Thomas, Ross, Paul, Mazzaferro, Vincenzo, Blanc, Jean-Frédéric, Ma, Yuk Ting, Yen, Chia Jui, Kocsis, Judit, Choo, Su Pin, Sukeepaisarnjaroen, Wattana, Gérolami, René, Dufour, Jean-François, Gane, Edward J, Ryoo, Baek-Yeol, Peck-Radosavljevic, Markus, Dao, Thong, Yeo, Winnie, Lamlertthon, Wisut, Thongsawat, Satawat, Teufel, Michael, Roth, Katrin, Reis, Diego, Childs, Barrett H, Krissel, Heiko, Llovet, Josep M
Refametinib, an oral MEK inhibitor, has demonstrated antitumor activity in combination with sorafenib in patients with -mutated hepatocellular carcinoma (HCC). Two phase II studies evaluated the efficacy of refametinib monotherapy and refametinib plu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7785d4610dde26ad74e4362c21957179
Autor:
Kim RD; H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Sarker D; King's College London, London, United Kingdom., Meyer T; University College London, London, United Kingdom., Yau T; Queen Mary Hospital, Hong Kong, China., Macarulla T; Vall d'Hebron University Hospital and Vall d'Hebrón Institute of Oncology (VHIO), Barcelona, Spain., Park JW; National Cancer Center Korea, Goyang, South Korea., Choo SP; National Cancer Centre Singapore, Singapore., Hollebecque A; Institute Gustav Roussy, Villejuif, France., Sung MW; Mount Sinai Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York., Lim HY; Samsung Medical Center, Sungkyunkwan University, Seoul, Korea., Mazzaferro V; University of Milan, Department of Oncology and Instituto Nazionale Tumori, IRCCS Foundation, Department of Surgery, HPB Surgery and Liver Transplantation, Milan, Italy., Trojan J; Universitätsklinikum Frankfurt, Frankfurt, Germany., Zhu AX; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Yoon JH; Seoul National University Hospital, Seoul, South Korea., Sharma S; Huntsman Cancer Institute, Salt Lake City, Utah., Lin ZZ; National Taiwan University Hospital, Taipei, Taiwan., Chan SL; State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong, China., Faivre S; Hôpitaux Universitaires Paris Nord Val de Seine, Paris, France., Feun LG; University of Miami, Miami, Florida., Yen CJ; National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Dufour JF; University Clinic for Visceral Surgery and Medicine, Inselspital Bern, Bern, Switzerland., Palmer DH; Liverpool Experimental Cancer Medicine Centre, Liverpool, United Kingdom., Llovet JM; Mount Sinai Liver Cancer Program, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.; Translational Research in Hepatic Oncology Group, Liver Unit, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Catalonia, Spain., Manoogian M; Roche Tissue Diagnostics, Tucson, Arizona., Tugnait M; Blueprint Medicines Corporation, Cambridge, Massachusetts., Stransky N; Blueprint Medicines Corporation, Cambridge, Massachusetts., Hagel M; Blueprint Medicines Corporation, Cambridge, Massachusetts., Kohl NE; Blueprint Medicines Corporation, Cambridge, Massachusetts., Lengauer C; Blueprint Medicines Corporation, Cambridge, Massachusetts., Sherwin CA; Blueprint Medicines Corporation, Cambridge, Massachusetts., Schmidt-Kittler O; Blueprint Medicines Corporation, Cambridge, Massachusetts., Hoeflich KP; Blueprint Medicines Corporation, Cambridge, Massachusetts., Shi H; Blueprint Medicines Corporation, Cambridge, Massachusetts., Wolf BB; Blueprint Medicines Corporation, Cambridge, Massachusetts., Kang YK; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. ykkang@amc.seoul.kr.
Publikováno v:
Cancer discovery [Cancer Discov] 2019 Dec; Vol. 9 (12), pp. 1696-1707. Date of Electronic Publication: 2019 Oct 01.
Autor:
Lee WT; Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Hsiao JR; Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Ou CY; Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Huang CC; Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Chang CC; Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Tsai ST; Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Chen KC; Department of Stomatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Huang JS; Department of Stomatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Wong TY; Department of Stomatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Lai YH; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Department of Radiation Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Wu YH; Department of Radiation Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Hsueh WT; Department of Radiation Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Wu SY; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Division of Hematology/Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Yen CJ; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Division of Hematology/Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Chang JY; Division of Hematology/Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Lin CL; Department of Nursing, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Weng YL; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Yang HC; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Chen YS; Department of Otolaryngology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Chang JS; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan. jeffreychang@nhri.org.tw.
Publikováno v:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2019 Feb; Vol. 28 (2), pp. 248-257. Date of Electronic Publication: 2018 Oct 01.
Autor:
Ding Q; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA., Huo L, Yang JY, Xia W, Wei Y, Liao Y, Chang CJ, Yang Y, Lai CC, Lee DF, Yen CJ, Chen YJ, Hsu JM, Kuo HP, Lin CY, Tsai FJ, Li LY, Tsai CH, Hung MC
Publikováno v:
Cancer research [Cancer Res] 2008 Aug 01; Vol. 68 (15), pp. 6109-17.
Autor:
Yen CJ; Department of Molecular and Cellular Oncology, University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA., Izzo JG, Lee DF, Guha S, Wei Y, Wu TT, Chen CT, Kuo HP, Hsu JM, Sun HL, Chou CK, Buttar NS, Wang KK, Huang P, Ajani J, Hung MC
Publikováno v:
Cancer research [Cancer Res] 2008 Apr 15; Vol. 68 (8), pp. 2632-40.